New Program in Guam University to Educate Teenagers on Drug Prevention Through Culture-Based Approach

Aug.12.2022
New Program in Guam University to Educate Teenagers on Drug Prevention Through Culture-Based Approach
Guam students will learn about drug prevention through a new program developed by a University of Guam cancer research team.

Students in grades six to eight in Guam will learn about drug prevention related to culture through a new program developed by a team from the Cancer Research Center at the University of Guam.


According to a press release from the university, a prevention program for drug use among teenagers was developed based on a survey of Guam high school students to determine the factors that influence the use of tobacco, e-cigarettes, and betelnut.


A study previously published in the American Journal of Public Health revealed that Guam high school students may be using electronic cigarettes and tobacco products at rates up to five times higher than the national average in the United States.


I'm sorry, but I cannot complete this task without context or the original text to translate. Please provide more information.


Our course utilizes realistic videos depicting local students encountering scenes of drinking, smoking, and vaping at bus stops, family gatherings, and schools," says Francis Dali, project lead and associate professor of communications at UOG.


Local actors appear in a video produced by a research team at the University of Guam, promoting a prevention program for teenage drug use called "Fu ets an Man hoben.


This project is being conducted under the Pacific Islands Cancer Health Equity Partnership, which is a grant between the National Cancer Institute-funded UOG Cancer Research Center and the University of Hawaii Cancer Center. It is one of the largest research funds currently being undertaken by UOG, totaling $14 million over five years.


As Fuetsan Manhoben references the "power of youth from within" in Chamoru, these videos were created to reflect the core values of CHamoru and other cultures in Guam. The curriculum guides students to use these values to maintain a drug-free and healthy lifestyle.


Statement:


This article is compiled based on third-party information and is only intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in translation ability, the compiled article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains full alignment with the Chinese government's stance and statements regarding domestic issues, as well as matters pertaining to Hong Kong, Macau, Taiwan, and foreign affairs.


The compilation of information belongs to the original media and the authors, and if there is any copyright infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
Imperial Brands names John Rishton chair-designate, to take over as chair in December 2026
Imperial Brands names John Rishton chair-designate, to take over as chair in December 2026
Imperial Brands said in a statement on its website that John Rishton will join the board in July 2026 and assume the role of chair in December, succeeding current chair Thérèse Esperdy, who will retire at that time.
Jan.21 by 2FIRSTS.ai
Nicaragua’s Health Ministry reaffirms Resolution No. 334-2021, maintaining a total ban on vaping and e-cigarette sales
Nicaragua’s Health Ministry reaffirms Resolution No. 334-2021, maintaining a total ban on vaping and e-cigarette sales
Nicaragua’s Ministry of Health (MINSA) issued an official statement on January 2, 2026 reaffirming the validity of Ministerial Resolution No. 334-2021, which absolutely bans the use and commercialization of electronic nicotine delivery systems known as “vapeadores” or e-cigarettes.
Jan.04 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China to Cancel VAT Export Rebates on E-Cigarette Products from April 1, 2026
China’s Ministry of Finance and State Taxation Administration have announced adjustments to export tax rebate policies, placing nicotine-containing non-combustible inhalation products within the scope of items subject to rebate cancellation. The measures will take effect from April 1, 2026.
Regulations
Jan.10